-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GlTLZYd7QGChwEDYOU7PCRopHhSyK2RR+jZhmoLFkPeV9Qdtfq/aiTA24b6nGxDt qqP14QZ728wmJ37T/Rj5QA== 0001047469-99-003568.txt : 19990208 0001047469-99-003568.hdr.sgml : 19990208 ACCESSION NUMBER: 0001047469-99-003568 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990205 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-48459 FILM NUMBER: 99522703 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KUMMELL INVESTMENTS LTD CENTRAL INDEX KEY: 0001032490 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 000000000 STATE OF INCORPORATION: J1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: STE 922C STREET 2: EUROPORT VIA LONDON CITY: GIBRALTAR STATE: J1 BUSINESS PHONE: 01135073440 MAIL ADDRESS: STREET 1: SUITE 922C STREET 2: EUROPORT (VIA LONDON) CITY: GIBRALTAR STATE: J1 SC 13G 1 SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ------ Cell Therapeutics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common - -------------------------------------------------------------------------------- (Title of Class of Securities) 150934107 ---------------------------------- (CUSIP Number) March 21, 1997 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) / / Rule 13d-1(c) /X/ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 150934107 --------- - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Kummell Investments Limited - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) / / of a Group (See Instructions) (b) / / Not Applicable - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Citizenship or Place of Organization British Virgin Islands - ------------------------------------------------------------------------------- Number of Shares (5) Sole Voting Power Beneficially 0 shares Owned by -------------------------------------------------- Each Reporting (6) Shared Voting Power Person With: 1,287,456 shares -------------------------------------------------- (7) Sole Dispositive Power 0 shares -------------------------------------------------- (8) Shared Dispositive Power 1,287,456 shares - ------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,287,456 shares - ------------------------------------------------------------------------------- (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / Not Applicable - ------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9) 8.342% - ------------------------------------------------------------------------------- (12) Type of Reporting Person (See Instructions) co - ------------------------------------------------------------------------------- ITEM 1. (a) Name of Issuer Cell Therapeutics, Inc. --------------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices 201 Elliot Ave. West, Suite 400, Seattle, WA 98119 --------------------------------------------------------------------- ITEM 2. (a) Name of Person Filing Kummell Investments Limited --------------------------------------------------------------------- (b) Address of Principal Business Office or, if none, Residence Suite 922C, Europort, Gibraltar --------------------------------------------------------------------- (c) Citizenship British Virgin Islands --------------------------------------------------------------------- (d) Title of Class of Securities Common Stock --------------------------------------------------------------------- (e) CUSIP Number 150934107 --------------------------------------------------------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) / / Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) / / Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) / / Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) / / Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) / / An investment adviser in accordance with section 240.13d-1(b)(1)(ii)(E). (f) / / An employee benefit plan or endowment fund in accordance with section 240.13d-1(b)(1)(ii)(F). (g) / / A parent holding company or control person in accordance with section 240.13d-1(b)(1)(ii)(G). (h) / / A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) / / A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) / / Group, in accordance with section 240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,287,456 shares --------------------------------------------------------------------------- (b) Percent of class: 8.342% --------------------------------------------------------------------------- (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote 0 shares ----------------------------------------------------------------- (ii) Shared power to vote or to direct the vote 1,287,456 shares ----------------------------------------------------------------- (iii) Sole power to dispose or to direct the disposition of 0 shares ----------------------------------------------------------------- (iv) Shared power to dispose or to direct the disposition of 1,287,456 shares ----------------------------------------------------------------- ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. / / Not Applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable ITEM 10. CERTIFICATION (a) The following certification shall be included if the statement is filed pursuant to section 240.13d-1(b): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to section 240.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 23, 1999 January 23, 1999 - -------------------------------------- -------------------------------------- Date Date /s/ Ho Tuen Yee /s/ Louise Mary Garbarino - -------------------------------------- -------------------------------------- Signature Signature Director Joint Secretary - -------------------------------------- -------------------------------------- Name/Title Name/Title ITEM 2. IDENTITY AND BACKGROUND This statement is filed by the following person (the Reporting Person): Kummell Investments Limited (a British Virgin Islands corporation engaged in the business of investing in securities, 100% of the outstanding capital stock of which is owned by Olive Holdings Limited), with its principal place of business at Suite 992C, Europort, Gibraltar. Olive Holdings Limited (a British Virgin Islands corporation with its principal place of business at Suite 922C, Europort, Gibraltar) is a holding company for various wholly owned subsidiaries which are engaged in the business of holding various investments. All of the outstanding capital stock of Olive Holdings Limited is owned by The OHL Trust. The OHL Trust is an Isle of Man trust. The principal business of The OHL trust is to own assets for the benefit of Mrs. Chan Tan Ching Fen and members of her family. The sole trustee of The OHL Trust is Echo Limited (an Isle of Man corporation) with its principal registered address at 3337 Athol Street, Douglas, Isle of Man. The principal business of Echo Limited is to act as trustee of The OHL Trust. The ultimate beneficial owner of The OHL Trust is Mrs. Chan Tan Ching Fen. Because Mrs. Chan has the authority to remove Echo Limited as trustee and to designate a successor trustee of The OHL Trust, Mrs. Chan may be considered to be ultimately in control of The OHL Trust and, through The OHL Trust of Olive Holdings Limited and Kummell Investments Limited. -----END PRIVACY-ENHANCED MESSAGE-----